Pricing Log in Create free account
Friday 6 November 2026 Export HAE’s income statement to Excel — free account

Haemonetics Corporation

HAE Healthcare Medical Devices

Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.

Revenue
+9.30%
EPS
+25.9%
Free cash flow
+20.4%
Total debt
+21.0%

Quarter to September 2026, against a year earlier

119.99 4.12 −3.32%
Market cap
$5.7B
P/E
54.5×
Fwd P/E
30.2×
Dividend yield
—
F-score
6/9
Altman Z
2.21
Beneish M
−2.81
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Haemonetics Corporation (HAE) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Haemonetics Corporation (HAE) trades at a EV/Sales of 4.7×. Over the past ten years it has ranged from 1.7× (May 2016) to 8.1× (February 2021); the current reading is higher than 76% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 2.7× (2.80%)
FY2025 2.8× (25.42%)
FY2024 3.8× (6.02%)
FY2023 4.0× 12.57%
FY2022 3.6× (49.53%)
FY2021 7.0× 33.25%
FY2020 5.3× 6.94%
FY2019 4.9× 21.10%
FY2018 4.1× 63.92%
FY2017 2.5× 11.36%

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.1× 26.96%
Jun 2026 3.2× 18.08%
Mar 2026 2.7× (16.64%)
Dec 2025 3.3× 47.39%
43 more quarters

Against its own ten years

Low 1.7× High 8.1×
Ten-year median 3.8×
Current reading's percentile 74

EV/Sales against peers

Company EV/Sales
BRKR Bruker Corporation compare 3.0×
ITGR Integer Holdings Corporation compare 3.0×
LIVN LivaNova PLC compare 3.2×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
HAE Haemonetics Corporation 4.7×
IRTC iRhythm Holdings, Inc. compare 5.2×
AXGN AxoGen, Inc. compare 8.8×
TXG 10x Genomics compare 11.5×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HAE